BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25732099)

  • 1. Can we protect from malignant arrhythmias by modulation of cardiac cell-to-cell coupling?
    Tribulova N; Szeiffova Bacova B; Benova T; Viczenczova C
    J Electrocardiol; 2015; 48(3):434-40. PubMed ID: 25732099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of myocardial gap junctions in electrical conduction and arrhythmogenesis.
    Kanno S; Saffitz JE
    Cardiovasc Pathol; 2001; 10(4):169-77. PubMed ID: 11600334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connexins and cardiac arrhythmias.
    van Rijen HVM; van Veen TAB; Gros D; Wilders R; de Bakker JMT
    Adv Cardiol; 2006; 42():150-160. PubMed ID: 16646589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemia-induced arrhythmia: the role of connexins, gap junctions, and attendant changes in impulse propagation.
    Cascio WE; Yang H; Muller-Borer BJ; Johnson TA
    J Electrocardiol; 2005 Oct; 38(4 Suppl):55-9. PubMed ID: 16226075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cardiac gap junction: a potential therapeutic target in the treatment of heart disease.
    Liu F; Gutstein DE
    Mt Sinai J Med; 2002 Nov; 69(6):421-4. PubMed ID: 12429963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cardiac gap-junction coupling: effects of antiarrhythmic peptide AAP10.
    Hagen A; Dietze A; Dhein S
    Cardiovasc Res; 2009 Jul; 83(2):405-15. PubMed ID: 19176598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Remodeling of cardiac gap junctions and arrhythmias].
    Yu ZB; Sheng JJ
    Sheng Li Xue Bao; 2011 Dec; 63(6):586-92. PubMed ID: 22193455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac muscle cell interaction: from microanatomy to the molecular make-up of the gap junction.
    Severs NJ
    Histol Histopathol; 1995 Apr; 10(2):481-501. PubMed ID: 7599443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of intercellular coupling in acute and chronic heart disease.
    Saffitz JE
    Braz J Med Biol Res; 2000 Apr; 33(4):407-13. PubMed ID: 10775305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac conduction and arrhythmia: insights from Nkx2.5 mutations in mouse and humans.
    Jay PY; Berul CI; Tanaka M; Ishii M; Kurachi Y; Izumo S
    Novartis Found Symp; 2003; 250():227-38; discussion 238-41, 276-9. PubMed ID: 12956333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors involved in the susceptibility of spontaneously hypertensive rats to low K+-induced arrhythmias.
    Tribulova N; Okruhlicova L; Imanaga I; Hirosawa N; Ogawa K; Weismann P
    Gen Physiol Biophys; 2003 Sep; 22(3):369-82. PubMed ID: 14986887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription enhancer factor-1-related factor-transgenic mice develop cardiac conduction defects associated with altered connexin phosphorylation.
    Chen HH; Baty CJ; Maeda T; Brooks S; Baker LC; Ueyama T; Gursoy E; Saba S; Salama G; London B; Stewart AF
    Circulation; 2004 Nov; 110(19):2980-7. PubMed ID: 15520314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of cell adhesion proteins and cardiac arrhythmogenesis.
    Li J; Patel VV; Radice GL
    Clin Med Res; 2006 Mar; 4(1):42-52. PubMed ID: 16595792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the autonomic nervous system in modulating cardiac arrhythmias.
    Shen MJ; Zipes DP
    Circ Res; 2014 Mar; 114(6):1004-21. PubMed ID: 24625726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connections, connections, connexins: towards systems biology paradigm of cardiac arrhythmia.
    Efimov IR
    J Mol Cell Cardiol; 2006 Dec; 41(6):949-51. PubMed ID: 17030039
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacotherapy of cardiac arrhythmias--basic science for clinicians.
    Shu J; Zhou J; Patel C; Yan GX
    Pacing Clin Electrophysiol; 2009 Nov; 32(11):1454-65. PubMed ID: 19744278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of thioridazine on gap junction intercellular communication in connexin 43-expressing cells.
    Matesic DF; Abifadel DN; Garcia EL; Jann MW
    Cell Biol Toxicol; 2006 Jul; 22(4):257-68. PubMed ID: 16685461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces cardiac arrhythmias in dystrophic mice.
    Colussi C; Berni R; Rosati J; Straino S; Vitale S; Spallotta F; Baruffi S; Bocchi L; Delucchi F; Rossi S; Savi M; Rotili D; Quaini F; Macchi E; Stilli D; Musso E; Mai A; Gaetano C; Capogrossi MC
    Cardiovasc Res; 2010 Jul; 87(1):73-82. PubMed ID: 20164117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gap junction alterations in human cardiac disease.
    Severs NJ; Coppen SR; Dupont E; Yeh HI; Ko YS; Matsushita T
    Cardiovasc Res; 2004 May; 62(2):368-77. PubMed ID: 15094356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined reduction of intercellular coupling and membrane excitability differentially affects transverse and longitudinal cardiac conduction.
    Stein M; van Veen TA; Remme CA; Boulaksil M; Noorman M; van Stuijvenberg L; van der Nagel R; Bezzina CR; Hauer RN; de Bakker JM; van Rijen HV
    Cardiovasc Res; 2009 Jul; 83(1):52-60. PubMed ID: 19389723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.